Aytu Biopharma (AYTU) EBIT Margin (2013 - 2026)
Aytu Biopharma's EBIT Margin came in at -4.82% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 45.54 percentage points from -50.37% a year earlier and up 27.92 percentage points from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) EBIT Margin (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma's EBIT Margin was -14.44%, down 2.65 percentage points from FY2025.
- EBIT Margin carries a five-year change of +75.25 percentage points (FY2021 to FY2026).
- Going back by fiscal year, EBIT Margin was -11.79% in FY2025 (-9.35 pp), -2.44% in FY2024 (+13.45 pp), -15.89% in FY2023 (+97.80 pp) and -113.69% in FY2022 (-24.00 pp).
- The fiscal Q4 2026 figure represents the highest quarterly EBIT Margin since fiscal Q3 2025.
- Year-over-year, EBIT Margin increased in two of the last eight quarters, with an average year-over-year change of -5.79 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in fiscal Q3 2023 (a gain of 183.11 percentage points), and the weakest in fiscal Q1 2022 (a drop of 100.19 percentage points).
- Business Quant data shows AYTU's EBIT Margin at -32.75% (Q3 2026), -12.99% (Q2 2026) and -10.83% (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | -4.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.82% |
| Mar 31, 2026 | -32.75% |
| Dec 31, 2025 | -12.99% |
| Sep 30, 2025 | -10.83% |
| Jun 30, 2025 | -50.37% |
| Mar 31, 2025 | 13.12% |
| Dec 31, 2024 | -10.45% |
| Sep 30, 2024 | -5.61% |
| Jun 30, 2024 | -15.58% |
| Mar 31, 2024 | -11.39% |
| Dec 31, 2023 | 16.78% |
| Sep 30, 2023 | -4.87% |
| Jun 30, 2023 | 0.55% |
| Mar 31, 2023 | -37.65% |
| Dec 31, 2022 | -26.13% |
| Sep 30, 2022 | -6.54% |
| Jun 30, 2022 | -61.72% |
| Mar 31, 2022 | -220.76% |
| Dec 31, 2021 | -48.84% |
| Sep 30, 2021 | -126.50% |
API Access
Aytu Biopharma EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();